A Study to Evaluate Safety, Engraftment, and Efficacy of VC-01 in Subjects With T1 Diabetes Mellitus

Clinical trial NCT04678557 · TERMINATED

Trial details

NCT number: NCT04678557
Sponsor: ViaCyte
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2019-06-25
Primary completion: 2021-11-12
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.